These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 4768318)

  • 1. Experimental and clinical studies on the metabolic fate of rifampicin in animals and in humans.
    Yokosawa A; Arai H; Sato H; Motomiya M; Oka S
    Sci Rep Res Inst Tohoku Univ Med; 1973 Dec; 19(4):177-82. PubMed ID: 4768318
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antitubercular activity and pharmacokinetics of rifampicin].
    Ginzburg TS; Drabkina RO
    Antibiotiki; 1972 Jul; 17(7):607-11. PubMed ID: 4655011
    [No Abstract]   [Full Text] [Related]  

  • 3. [Rifampicin and its clinical use].
    Fafrowicz B
    Wiad Lek; 1971 Jul; 24(3):233-8. PubMed ID: 4926926
    [No Abstract]   [Full Text] [Related]  

  • 4. Rifampicin, a general review.
    Binda G; Domenichini E; Gottardi A; Orlandi B; Ortelli E; Pacini B; Fowst G
    Arzneimittelforschung; 1971 Dec; 21(12):1907-77. PubMed ID: 4945790
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pharmacokinetics of rifampicin in experimental animals and in man].
    Curci G; Ninni A
    Lotta Tuberc; 1971; 41(3):354-66. PubMed ID: 5291093
    [No Abstract]   [Full Text] [Related]  

  • 6. Rifampicin (600 mg) kinetics in the undernourished.
    Polasa K; Krishnaswamy K
    Indian J Med Res; 1986 Feb; 83():175-8. PubMed ID: 3710544
    [No Abstract]   [Full Text] [Related]  

  • 7. [Rifampicin, a new antitubercular bactericide].
    Thibault P
    Presse Med (1893); 1970 Feb; 78(11):501-2. PubMed ID: 5418624
    [No Abstract]   [Full Text] [Related]  

  • 8. [Intermittent treatment with Rifampicin in experimental tuberculosis in guinea pigs].
    Nitti V; Ninni A; Marsico SA
    Arch Tisiol Mal Appar Respir; 1969 Dec; 24(12):923-43. PubMed ID: 5312739
    [No Abstract]   [Full Text] [Related]  

  • 9. [Rifampicin kinetics in enphropathic subjects].
    Borghetti A; Di Perna A; Novarini A; Bruschi G; Montanari A
    G Clin Med; 1970 Nov; 51(11):857-76. PubMed ID: 5512465
    [No Abstract]   [Full Text] [Related]  

  • 10. Recent investigations on the biological properties of rifampicin.
    Furesz S
    Acta Tuberc Pneumol Belg; 1969; 60(3):266-9. PubMed ID: 5371663
    [No Abstract]   [Full Text] [Related]  

  • 11. [Rifampicin preparations for internal use and their bioavailability].
    Zak AF; Batuashvili TA; Shchedrin VI
    Antibiotiki; 1981 Oct; 26(10):728-31. PubMed ID: 7305309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experimental pharmacodynamic study of rifampicin administered by various methods].
    Shapovalov VP; Mil'chenko KP; Kovalenko NN
    Antibiotiki; 1982 Jun; 27(6):434-7. PubMed ID: 7114830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rifampicin.
    Polascik M; Golden B
    Ann Ophthalmol; 1971 Aug; 3(8):877-82. PubMed ID: 5005929
    [No Abstract]   [Full Text] [Related]  

  • 14. [Lymphogenic introduction into lesser circulation of orally administered rifampicin in standard and liposomal forms].
    Petrenko TI; Ursov IG; Kurunov IuN; Borodin IuI; Sidorova LD
    Probl Tuberk; 1995; (3):53-4. PubMed ID: 7617640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local diffusibility of rifampicin in tuberculous lesions of bone and joint.
    Popescu E; Algeorge G; Paunescu E; Stoinescu M; Rudescu D
    Respiration; 1971; 28():Suppl:44-51. PubMed ID: 5150795
    [No Abstract]   [Full Text] [Related]  

  • 16. [Research on the protective action of rifampicin administered intermittently in experimental tuberculosis in guinea pigs].
    Algeorge G; Sibilla S; Rudesco D
    Ann Pediatr (Paris); 1970 Oct; 17(10):674. PubMed ID: 5475418
    [No Abstract]   [Full Text] [Related]  

  • 17. [An experimental study on the antituberculous activity of rifampicin].
    Toyoara M
    Kekkaku; 1971 Jun; 46(6):211-6. PubMed ID: 4997827
    [No Abstract]   [Full Text] [Related]  

  • 18. [Correlations between the biological properties and structure of rifampicin].
    Sensi P
    G Ital Mal Torace; 1969; ():Suppl 2:40-9. PubMed ID: 5357138
    [No Abstract]   [Full Text] [Related]  

  • 19. [Animal experimental studies on the effect of rifampicin on pathogenic gas gangrene bacilli].
    Schallehn G
    Schweiz Med Wochenschr; 1969 Jul; 99(29):1057-9. PubMed ID: 5802010
    [No Abstract]   [Full Text] [Related]  

  • 20. [Biological characteristics of rifampicin-resistant Mycobacterium tuberculosis].
    Klimenko MT
    Antibiotiki; 1984 Mar; 29(3):185-8. PubMed ID: 6428304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.